Nonviral pulmonary delivery of siRNA.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Accounts of Chemical Research

• Publication date

  2012-07-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1021/ar200110pPMID 21905687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis.

  2011cited by this paper
• Local pulmonary immunotherapy with siRNA targeting TGFβ1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice.

  2011cited by this paper
• Polymer-related off-target effects in non-viral siRNA delivery.

  2011cited by this paper
• In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers.

  2011cited by this paper
• Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability--A step closer from promising technology to application.

  2011cited by this paper
• Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA

  2011cited by this paper
• Comparative in vivo study of poly(ethylene imine)/siRNA complexes for pulmonary delivery in mice.

  2011cited by this paper
• Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis

  2011cited by this paper
• Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury*

  2010cited by this paper
• Clinical status of duplex RNA.

  2010cited by this paper
• Attenuation of fibrosis in vitro and in vivo with SPARC siRNA

  2010cited by this paper
• RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice.

  2010cited by this paper
• Pulmonary Gene Silencing in Transgenic EGFP Mice Using Aerosolised Chitosan/siRNA Nanoparticles

  2010cited by this paper
• Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice.

  2010cited by this paper
• Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis

  2010cited by this paper
• Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model

  2009cited by this paper
• Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug

  2009cited by this paper
• Naked siLNA-Mediated Gene Silencing of Lung Bronchoepithelium EGFP Expression After Intravenous Administration

  2009cited by this paper
• The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.

  2009cited by this paper
• In vivo SPECT and real-time gamma camera imaging of biodistribution and pharmacokinetics of siRNA delivery using an optimized radiolabeling and purification procedure.

  2009cited by this paper
• WT1 gene silencing by aerosol delivery of PEI–RNAi complexes inhibits B16-F10 lung metastases growth

  2009cited by this paper
• Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis.

  2009cited by this paper
• Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.

  2009cited by this paper
• Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor

  2008cited by this paper
• Extracellular barriers in respiratory gene therapy☆

  2008cited by this paper
• Inhibition of influenza A virus replication by short double-stranded oligodeoxynucleotides

  2008cited by this paper
• siRNA and the lung: research tool or therapeutic drug?

  2008cited by this paper
• Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation

  2008cited by this paper
• Inhalable siRNA: potential as a therapeutic agent in the lungs.

  2008cited by this paper
• Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis.

  2008cited by this paper
• Small interfering RNA against interleukin-5 decreases airway eosinophilia and hyper-responsiveness

  2008cited by this paper
• RNA Interference Inhibits Respiratory Syncytial Virus Replication and Disease Pathogenesis without Inhibiting Priming of the Memory Immune Response

  2008cited by this paper
• Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy

  2008cited by this paper
• Targeted delivery of magnetic aerosol droplets to the lung

  2007cited by this paper
• Pulmonary delivery of nucleic acids

  2007cited by this paper
• Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity.

  2007cited by this paper
• Genetic Vaccines and Therapy

  2007cited by this paper
• In vivo animal models for drug delivery across the lung mucosal barrier.

  2007cited by this paper
• Nonviral delivery of synthetic siRNAs in vivo.

  2007cited by this paper
• Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs.

  2007cited by this paper
• RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system.

  2006cited by this paper
• Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.

  2006cited by this paper
• Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung.

  2006cited by this paper
• RNA interference for alpha-ENaC inhibits rat lung fluid absorption in vivo.

  2006cited by this paper
• RNA interference for α-ENaC inhibits rat lung fluid absorption in vivo

  2006cited by this paper
• Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo

  2006cited by this paper
• RNAi therapeutics: a potential new class of pharmaceutical drugs

  2006cited by this paper
• A pathogen-inducible endogenous siRNA in plant immunity

  2006cited by this paper
• Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene

  2005cited by this paper
• Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI.

  2005cited by this paper
• Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung.

  2005cited by this paper
• Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles

  2005cited by this paper
• Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis.

  2005cited by this paper
• Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque

  2005cited by this paper
• In vivo gene silencing (with siRNA) of pulmonary expression of MIP‐2 versus KC results in divergent effects on hemorrhage‐induced, neutrophil‐mediated septic acute lung injury

  2005cited by this paper
• Inhibition of respiratory viruses by nasally administered siRNA

  2005cited by this paper
• Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy

  2005cited by this paper
• Functional MRI of the lung using hyperpolarized 3‐helium gas

  2004cited by this paper
• siRNAs: applications in functional genomics and potential as therapeutics

  2004cited by this paper
• Inhibition of influenza virus production in virus-infected mice by RNA interference.

  2004cited by this paper
• Protection against lethal influenza virus challenge by RNA interference in vivo.

  2004cited by this paper
• Small Interfering RNA Targeting Heme Oxygenase-1 Enhances Ischemia-Reperfusion-induced Lung Apoptosis*

  2004cited by this paper
• Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice.

  2004cited by this paper
• Biodistribution of phosphodiester and phosphorothioate siRNA.

  2004cited by this paper
• RNA Interference: Biology, Mechanism, and Applications

  2003cited by this paper
• Argonaute2, a Link Between Genetic and Biochemical Analyses of RNAi

  2001cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Developments in liposomal drug delivery systems

  2001cited by this paper
• Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes.

  2000cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper

• siRNA-based nanotherapeutics for malignant and non-malignant diffuse parenchymal lung diseases

  2026cites this paper
• Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA Viruses

  2025cites this paper
• Improving inhalation delivery of biologics with extra-large particles produced by spray freeze drying

  2025cites this paper
• Inhalable perfluorocarbon RNA nanocapsules overcome biological barriers to treat lung metastases.

  2025cites this paper
• Unveiling the translational and therapeutic potential of small interfering RNA molecules in combating SARS-CoV-2: A review.

  2025cites this paper
• Impact of Formulation and Process Parameters on the Stability and Bioactivity of RNA-Loaded Lipid Nanoparticles during Nebulization.

  2025cites this paper
• Inhalable Perfluorocarbon RNA Nanocapsules Bypass Immune Clearance While Targeting Lung Epithelial and Lung Tumor Cells

  2025cites this paper
• Pulmonary Drug Delivery through Responsive Materials

  2024influential citation
• Pulmonary RNA Interference against Acute Lung Injury Mediated by Mucus- and Cell-penetrating Nanocomplexes.

  2024cites this paper
• Polyphenolic Nanoparticle Platforms (PARCELs) for In Vitro and In Vivo mRNA Delivery.

  2024cites this paper
• Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges

  2023cites this paper
• Potensi Small Interference RNA (SiRNA) Inhalasi dalam Menghambat Replikasi Dan Transkripsi SARS-Cov-2

  2023cites this paper
• A self-amplified ferroptosis nanoagent that inhibits the tumor upstream glutathione synthesis to reverse cancer chemoresistance.

  2023cites this paper
• Targeted GATA3 knockdown in activated T cells via pulmonary siRNA delivery as novel therapy for allergic asthma.

  2023cites this paper
• Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract

  2022cites this paper
• Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases

  2022cites this paper
• Transposition of polymer-encapsulated small interfering RNA through lung surfactant models at the air-water interface

  2022cites this paper
• Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery

  2022cites this paper
• Can pulmonary RNA delivery improve our pandemic preparedness?

  2022cites this paper
• Delivery of synthetic mRNAs for tissue regeneration.

  2021cites this paper
• Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes

  2021cites this paper
• Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions

  2021cites this paper
• siRNA Therapeutics against Respiratory Viral Infections—What Have We Learned for Potential COVID‐19 Therapies?

  2021cites this paper
• Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread

  2021cites this paper
• Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung

  2021cites this paper
• Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges.

  2020cites this paper
• Systematic analysis of RNAi-accessible SARS-CoV-2 replication steps identi�es ORF1 as promising target

  2020cites this paper
• Highly sensitive and selective colorimetric probe for detection of Cu2+ in aqueous medium based on rhodamine B

  2020cites this paper
• Pulmonary Administration: Strengthening the Value of Therapeutic Proximity

  2020cites this paper
• Systematic analysis of RNAi-accessible SARS-CoV-2 replication steps identifies ORF1 as promising target

  2020cites this paper
• Nanoparticles‐assisted delivery of antiviral‐siRNA as inhalable treatment for human respiratory viruses: A candidate approach against SARS‐COV‐2

  2020cites this paper
• T-cell targeted pulmonary siRNA delivery for the treatment of asthma.

  2020cites this paper
• Polyprenol-Based Lipofecting Agents for In Vivo Delivery of Therapeutic DNA to Treat Hypertensive Rats

  2020cites this paper
• RNAi therapeutic strategies for acute respiratory distress syndrome

  2019cites this paper
• Pulmonary delivery of siRNA as a novel treatment for lung diseases.

  2019cites this paper
• Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

  2019cites this paper
• Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles

  2019cites this paper
• Optimized combination of cationic lipids and neutral helper lipids in cationic liposomes for siRNA delivery into the lung by intravenous injection of siRNA lipoplexes

  2019cites this paper
• Naked pDNA Inhalation Powder Composed of Hyaluronic Acid Exhibits High Gene Expression in the Lungs.

  2018cites this paper
• Nonlinear Supramolecular Polymers for Therapeutic Applications

  2018cites this paper
• The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis

  2018cites this paper
• Formulation of RNA interference-based drugs for pulmonary delivery: challenges and opportunities.

  2018cites this paper
• Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex

  2018cites this paper
• Bridging the Gap between the Bench and the Clinic : Asthma

  2017cites this paper
• Luminescent Ruthenium(II) Polypyridyl Complexes as Nonviral Carriers for DNA Delivery.

  2017cites this paper
• Theranostic Prodrug Vesicles for Imaging Guided Codelivery of Camptothecin and siRNA in Synergetic Cancer Therapy.

  2017cites this paper
• Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems.

  2017cites this paper
• Synthesis, structural characterization and biological properties of phosphorescent iridium(III) complexes.

  2017cites this paper
• From Genesis to Revelation: The Role of Inflammatory Mediators in Chronic Respiratory Diseases and their Control by Nucleic Acid-based Drugs.

  2016cites this paper
• The suppression of metastatic lung cancer by pulmonary administration of polymer nanoparticles for co-delivery of doxorubicin and Survivin siRNA.

  2016cites this paper
• Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptides.

  2016cites this paper
• This item is the archived peer-reviewed author-version of: Bio-inspired materials in drug delivery: exploring the role of pulmonary surfactant in sIRNA inhalation therapy

  2016cites this paper
• Therapeutic delivery of RNA effectors: diseases affecting the respiratory system.

  2016cites this paper
• Inter-molecular β-sheet structure facilitates lung-targeting siRNA delivery

  2016cites this paper
• Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.

  2016cites this paper
• Antibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion

  2016cites this paper
• Advances in Pulmonary Drug Delivery

  2016cites this paper
• Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance.

  2016cites this paper
• Pulmonary administration of small interfering RNA: The route to go?

  2016cites this paper
• Inhalation Properties and Stability of Nebulized Naked siRNA Solution for Pulmonary Therapy.

  2016cites this paper
• The advantages of pulmonary delivery of therapeutic siRNA.

  2015cites this paper
• Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier.

  2015cites this paper
• Dendrimer nanoconjugates and their oral inhalation formulations for lung cancer therapy

  2015cites this paper
• A dendritic nano-sized hexanuclear ruthenium(II) complex as a one- and two-photon luminescent tracking non-viral gene vector

  2015cites this paper
• Dry Powder Inhalation for Pulmonary Delivery: Recent Advances and Continuing Challenges

  2015cites this paper
• Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.

  2015cites this paper
• Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platform.

  2015cites this paper
• Exploring MicroRNA Expression Profiles Related to the mTOR Signaling Pathway in Mouse Embryonic Fibroblast Cells Treated with Polyethylenimine.

  2015cites this paper
• Modified Poly(lactic‐co‐glycolic Acid) Nanoparticles for Enhanced Cellular Uptake and Gene Editing in the Lung

  2015cites this paper
• Lipophilic tetranuclear ruthenium(II) complexes as two-photon luminescent tracking non-viral gene vectors.

  2015cites this paper
• siRNA delivery to the lung: what's new?

  2014cites this paper
• Star-Shaped Tetraspermine Enhances Cellular Uptake and Cytotoxicity of T-Oligo in Prostate Cancer Cells

  2014cites this paper
• Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.

  2014cites this paper
• Molecular mechanisms and physiology of disease

  2014cites this paper
• Development of Pre-Clinical Models for Evaluating the Therapeutic Potential of Candidate siRNA Targeting STAT6

  2014cites this paper
• Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo

  2014cites this paper
• siRNA delivery targeting to the lung via agglutination-induced accumulation and clearance of cationic tetraamino fullerene

  2014cites this paper
• Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies.

  2014cites this paper
• Nanocarriers for respiratory diseases treatment: recent advances and current challenges.

  2014influential citation
• Low molecular weight PEI-appended polyesters as non-viral gene delivery vectors.

  2014cites this paper
• Dendrimer Nanocarriers for Transport Modulation Across Models of the Pulmonary Epithelium

  2014cites this paper
• Quo vadis polyplex?

  2014cites this paper
• Pulmonary Drugs and Genes Delivery Systems for Lung Disease Treatment

  2014cites this paper
• The Significance of Nanoparticles in Medicine and Their Potential Application in Asthma

  2014cites this paper
• Poly(ethylene glycol)-block-cationic polylactide nanocomplexes of differing charge density for gene delivery.

  2013cites this paper
• Polymeric Nanocarriers And Their Oral Inhalation Formulations For The Regional Delivery Of Nucleic Acids To The Lungs

  2013cites this paper
• Routes of Delivery for Biological Drug Products

  2013cites this paper
• Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery.

  2013cites this paper
• Enhanced Intrapulmonary Delivery of Anticancer siRNA for Lung Cancer Therapy Using Cationic Ethylphosphocholine-based Nanolipoplexes

  2013cites this paper
• The influence of natural pulmonary surfactant on the efficacy of siRNA-loaded dextran nanogels.

  2013cites this paper
• Peptide Dendrimer/Lipid Hybrid Systems Are Efficient DNA Transfection Reagents: Structure–Activity Relationships Highlight the Role of Charge Distribution Across Dendrimer Generations

  2013cites this paper
• Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA

  2013cites this paper
• Oligonucleotide Delivery to the Lung: Waiting to Inhale

  2012cites this paper
• Pulmonary gene delivery using polymeric nonviral vectors.

  2012cites this paper
• Polymeric nanocarriers for the regional and systemic delivery of therapeutics to and through the lungs

  2012influential citation
• Mucosal Delivery of RNAi Therapeutics

  2012cites this paper
• Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice

  2012cites this paper
• Controlled pulmonary drug and gene delivery using polymeric nano-carriers.

  2012cites this paper
• Efficient DNA condensation induced by ruthenium(II) complexes of a bipyridine-functionalized molecular clip ligand.

  2012cites this paper
• RNA interference in vitro and in vivo using DsiRNA targeting the nucleocapsid N mRNA of human metapneumovirus.

  2012cites this paper